The nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals

For more information please click on the following link:


Nuclear Medicine and Radiopharmaceuticals Manufacturing Market | Market Size | 2030

Market research report on nuclear medicine and radiopharmaceuticals manufacturing with a focus on current market landscape and future growth opportunities